A webcast of the fireside chat will be available on-demand beginning
About
Investor Relations Contact:
(212) 600-1902
Codexis@argotpartners.com
![](https://ml.globenewswire.com/media/NmJmNTg3NWMtM2IwMi00NzhkLWI5NDEtNDllODdhNzgxY2I2LTEwMjgxMDc=/tiny/Codexis-Inc-.png)
2022 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 USD | -7.28% |
|
+18.62% | +12.79% |
Jul. 01 | Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics | MT |
May. 30 | Cantor Fitzgerald Starts Codexis With Overweight Rating, $11 Price Target | MT |
A webcast of the fireside chat will be available on-demand beginning
About
Investor Relations Contact:
(212) 600-1902
Codexis@argotpartners.com
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+12.79% | 243M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+48.94% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |